| Literature DB >> 25471485 |
Rasha Khatib, Nancy Santesso, Laura Pickard, Osman Osman, Lora Giangregorio, Carly Skidmore, Alexandra Papaioannou1.
Abstract
BACKGROUND: The risk factors associated with fractures have been well-characterized in community dwelling populations, but have not been clearly defined in long-term care (LTC) settings. The objective of this review was to identify risk factors for fractures in LTC settings.Entities:
Mesh:
Year: 2014 PMID: 25471485 PMCID: PMC4266898 DOI: 10.1186/1471-2318-14-130
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Figure 1PRISMA flow diagram.
Characteristics of included studies
| Author | Country | Setting | Age, mean (μ) ± SD | % females | Sample size | Follow-up | Outcome |
|---|---|---|---|---|---|---|---|
| Berry, 2008 [ | USA | 1 LTC | μ: 89.0 (±6.1) | 79% | 184 | 8.5 years | Osteoporotic fractures |
| Broe, 2000 [ | USA | 1 LTC | μ: 88.0 (±6.2) | 74% | 252 | 6.6 years | Osteoporotic fractures |
| Chandler, 2000 [ | USA | 47 NH | μ: 85.0 (±7.0) | 100% | 1427 | 18 months | Osteoporotic fractures |
| Chen, 2009 [ | Australia | NH, ICF | μ: 85.6 | 75% | 1,894 | 4 years | Hip fracture |
| Free dataset | |||||||
| Colon-Emeric, 2003 [ | USA | NH | Fracture group μ: 81.96 ± 0.19 | Fracture group 79% | 13,516 | 1-2 years | Hip fracture |
| MDS dataset | |||||||
| No fracture group: 68% | |||||||
| No fracture group μ: 80.83 ± 0.05 | |||||||
| Dobnig, 2007 [ | Austria | NH | Ctrl μ: 83.8 (±6.2), Hip fracture μ: 83.6 (±6.3), Non-vertebral. Fracture μ 83.8 (±6.3) | 100% | 1,664 | 2 years | Hip* and Non- vertebral fracture |
| 95 homes | |||||||
| Huybrechts, 2011 [ | Canada | NH | Atypical antipsychotics μ: 84.0 (±6.6) | Atypical antipsychotics: 58% | 10,900 | 180 days | Femoral Fracture |
| Data from BC Ministry of Health | |||||||
| Conventional antipsychotics μ: 83.0 (±6.8) | Conventional antipsychotics: 55% | ||||||
| Huybrechts, 2012 [ | USA | NH | Conventional antipsychotics μ: 83.3 | Conventional APMs: 69% atypical AMPS: 75% | 83,959 | 180 days | Hip fracture |
| MDS, Medicaid, OSCAR | |||||||
| Atypical antipsychotics: 83.3 | |||||||
| Lyles, 2008 [ | USA | NH | Prior hip fractures μ: 83.3, Other fractures μ: 78.8 | Prior hip fractures: 83% Other fractures: 80% | 30,665 | 2 years | Osteoporotic fractures |
| MDS and Medicare in North Carolina | |||||||
| No prior fracture μ: 80.2 | No prior fracture: 63% | ||||||
| Nakamura, 2010 [ | Japan | 140 NH | Women μ: 85.5 (±7.5), Men μ: 80.3 (±8.6) | 76% | 8,905 | 1 year | Hip fracture |
| Visenten, 1995 [ | Italy | 1 NH | μ 81.5 (±8.0) | 76% | 197 | 3 years | Osteoporotic fractures |
LTC = long term care; NH = nursing home; ICF = Intermediate Care Facility; MDS = Minimum Dataset; FREE = Fracture Risk Epidemiology in the Frail Elderly; BC = British Colombia.
*When results for 2 fracture sites were reported, we only included results of hip fractures.
**Study analysis restricted to subpopulation of long term care residents.
Summary of effect of FRAX and other predictors of fracture risk in long term care patients
| Risk factor | N studies and participants | Association with fractures | Confidence in effect |
|---|---|---|---|
|
| |||
| Prior fractures | Pooled: 6 studies; 56,781 participants | Moderate increase in risk | Moderate |
| RR = 1.71, 95%CI = 1.30-2.24 | ⊕ ⊕ ⊕O | ||
| Female gender | Pooled: 3 studies; 44,433 participants | Small increase in risk | Moderate |
| RR = 1.40, 95%CI = 1.00-1.95 | ⊕ ⊕ ⊕O | ||
| Lower BMI* | Pooled: 2 studies; 1,729 participants | Little to no increase in risk HR = 0.94, 95%CI = 0.90-0.98 | low |
| Not pooled: 1 study; 128 participants | ⊕ ⊕ OO | ||
| Older age | Not pooled: 5 studies; 44,745 participants | Small increase in risk | low |
| ⊕ ⊕ OO | |||
| Low BMD | Not pooled: 2 studies; 1,708 participants | Moderate to large increase in risk | low |
| ⊕ ⊕ OO | |||
| Glucocorticoid use | Not pooled: 1 study; 1,550 participants | Moderate to large increase in risk | low |
| ⊕ ⊕ OO | |||
| Rheumatoid arthritis | Not pooled: 1 study; 30,665 participants | Little to no increase in risk | low |
| ⊕ ⊕ OO | |||
|
| |||
| Psychotropic medication use | Pooled: 3 studies; 45,962 participants | Uncertain | Very low |
| Not pooled: 2 studies; 94,859 participants | ⊕OOO | ||
| Cognitive impairment | Pooled: 2 studies; 14,773 participants | Small increase in risk | Moderate |
| Not pooled: 1 study; 1,894 participants | RR = 1.53, 95%CI = 1.09-2.14 | ⊕ ⊕ ⊕O | |
| Mobility | Not pooled: 3 studies; 30,132 participants | Uncertain | Very low |
| ⊕OOO | |||
| Falls | Pooled: 4 studies; 44,560 participants | Small to moderate increase in risk | Moderate |
| RR = 1.28, 95%CI = 1.04-1.58 | ⊕ ⊕ ⊕O | ||
*Since both studies included in the meta analysis of BMI reported Hazard Ratios, we did not convert them into relative risks and report pooled results as hazard ratios.
Figure 2Pooled effect of each risk factor on future fractures.
Results of individual studies reporting the effect of age on fracture risk
| Study | Total fractures | Total no fractures | Age group | Effect measure (95% CI) |
|---|---|---|---|---|
| Broe, 2000 [ | 63 | 189 | Per 5 years | RR = 1.18 (0.91-1.53) |
| Colon- Emeric, 2003 [ | 635 | 12,881 | Per year | OR = 1.03 (1.01,1.04) |
| Visentin, 1995 [ | 41 | 87 | Per 1 SD | RR = 1.7 (1.1-2.3) |
| Berry, 2012 [ | 39 | 145 | Per year | HR = 0.97 (0.92–1.01) |
| Lyles, 2008 [ | 3,381 | 27,284 | 50-64 years | Ref |
| 65-74 years | HR = 1.10 (0.89 1.37) | |||
| 75- 84 years | HR = 1.25 (1.02 1.54) | |||
| 85+ | HR = 1.38 (1.13 1.70) |
RR = Relative Risk, OR = Odds Ratio, HR = Hazard Ratio, SD = standard deviation.